Covid update

Fill and Finish

BioConnection offers clinical and commercial Fill and Finish for your products. Our capabilities include liquid fill or lyophilization intended for vials, prefilled syringes or blowfill seals. Fill and Finish is the core of our company!

Clinical scale manufacturing

Our cornerstone is the clinical scale manufacturing plant in Oss. Via this plant, that complies with EMA and FDA regulations, we can provide you with the automated fill of clinical grade cGMP products in vials and syringes,  both liquid and freeze-dried. Thanks to our network, we can also provide you with the handfill of vials, syringes and Fill and Finish almost any other container format, leading to a very flexible approach. Due to the efforts of BioConnection we can provide you a seamless transfer from the handfill unit to the automated unit.

Commercial scale-up of your product

We can also facilitate your commercial launch from this plant. Further commercial scale-up and manufacturing beyond our in-house scale is arranged through our network or we can transfer to your preferred supplier. You have total flexibility and control regarding the process, enabling a strategic fit between our capabilities and your wishes.

Please see the summary of our services below to view our capacities per vial, ampoule, syringe. We can’t wait to work with you!

Summary of our services

Drug product development

  • Formulation development
  • Process and analytical development & validation
  • Lyo-cycle development and/or optimization
  • Transfer and scale-up to clinic
  • Transfer and scale-up to market

Freeze drying

  • Shelf areas ranging from 3 m² up to 10 m²

Clinical trial material services

  • Labeling
  • Clinical trial packaging
  • QP release
  • Storage

Fill and Finish

  • Batch sizes: from 1 unit up to 150,000 units per batch
  • Clinical and commercial scale
  • Automated fill and hand fill
  • Aseptic filling
  • Vials: from 2 RDIN up to 50 RDIN
  • Syringes: from 0.5 ml up to 10 ml
  • Other primary packs: via handfill
  • Terminal sterilization

Covid-19 update BioConnection

BioConnection has taken precautions related to the global outbreak of the Covid-19 virus. To start with; we are currently in full operation and running on-schedule with regard to our planned productions. Our production department is on full strength and we have no shortages of material(s) nor do we foresee them.

For our personnel we are following the guidelines as issued by the Dutch National Institute for Public Health and the Environment, RIVM ( This means that people stay at home when they show (early) symptoms connected to Covid-19. Furthermore BioConnection employees work from home as much as possible. We avoid shaking hands and keep distance from each other. We take every precaution as advised to prevent the spread of the Covid-19 virus and will fully comply to the requests as stated and/or enforced by the authorities.

Our expansion project ( is running as planned to start GMP production in Q2 2021. We stay in close contact with our suppliers for the production equipment.

We review for Covid policy changes by the authorities on a daily base and adapt to them. If changes occur, this statement will be updated accordingly so you always have the latest information. In case you have any questions, please do not hesitate to contact us via our general number or website. Current customers of BioConnection, can contact their dedicated program manager. In case you want BioConnection to become a partner in your development or manufacturing, please contact our Business Development department via

The BioConnection Management Team.

You have Successfully Subscribed!